Levels of pro-inflammatory cytokines and NO in atopic (AA), non atopic asthmaticus (NAA) and healthy children Source: Eur Respir J 2004; 24: Suppl. 48, 596s Year: 2004
Comparison of blood ILC2 cell numbers, phenotypes and proliferation between atopic severe asthma participants, healthy controls with atopy and non-atopic healthy controls Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020
Plasma leukotriene level in atopic and non-atopic asthmatic children and its correlation to severity of the disease Source: Eur Respir J 2003; 22: Suppl. 45, 314s Year: 2003
Serum levels of interleukin-1α in patients affected by atopic and non atopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 290s Year: 2003
The role of IgE (FcεRI-β) gene polymorphisms in patients with atopic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 381s Year: 2005
The mechanisms of glucocorticoid (GC)-induced lymphocyte apoptosis in atopic bronchial asthma (ABA) Source: Eur Respir J 2002; 20: Suppl. 38, 29s Year: 2002
The role of mepolizumab in atopic and nonatopic severe asthma with persistent eosinophilia Source: Eur Respir J 2014; 44: 239-241 Year: 2014
MMP-9 gene variants increase the risk for non-atopic asthma in children Source: Annual Congress 2010 - Phenotypes, mechanisms and diagnosis of asthma in childhood Year: 2010
IL-5 and GM-CSF positive cells in induced sputum from asthmatics and patients with non-allergic rhinitis with eosinophilia syndrome (NARES) Source: Eur Respir J 2001; 18: Suppl. 33, 529s Year: 2001
Omalizumab therapy of the children with uncontolled atopic bronchial asthma (BA) Source: Annual Congress 2010 - Clinical aspects and treatment of asthma and allergic respiratory diseases Year: 2010
Omalizumab reduces asthma exacerbations in children (6–<12 years) with moderate-to-severe allergic (IgE-mediated) asthma irrespective of baseline LABA use Source: Annual Congress 2009 - Drug treatment of childhood asthma: the controversies and the issues Year: 2009
A comparison of clinical characteristics between cough variant asthma (CVA) and bronchial asthma (BA) in adult patients Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up Year: 2010
Different immunoregulatory background in atopic and nonatopic asthma in children Source: Eur Respir J 2001; 18: Suppl. 33, 369s Year: 2001
Inflammatory cytokines in serum from children with severe asthma compared to controlled asthmatics Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy Year: 2012
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges Year: 2009
Interleukin-4 (IL-4) and NO metabolites in the exhaled air condensates (EAC) of atopic children as a predictor of asthma development Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001
The relation between atopic and non-atopic asthma and PPD response Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009
Serum GAL3 predict response in omalizumab-treated patients with severe allergic asthma: the PROXIMA study Source: International Congress 2018 – Innovative therapies in asthma and COPD Year: 2018
The effects of IL12B promoter polymorphism on co-existence of allergic rhinitis or familial asthma history, serum total IgE and eosinophil level in asthma patients Source: Annual Congress 2008 - Advances in functional genomics of neoplastic and non-neoplastic lung diseases Year: 2008
IL-33 mRNA in induced sputum cells from allergic rhinitis and asthma patients: a marker of Th-2 phenotype status? Source: International Congress 2017 – Monitoring asthma control Year: 2017